Efficacy Trial on Meningococcal B Vaccine for Preventing Gonorrhea Infections

PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

May 4, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions

GonorrheaSexually Transmitted Infection

Interventions

BIOLOGICAL

4CMenB vaccine

Four-component MenB vaccine

OTHER

Placebo

0.9% Sodium Chloride Inj. B.P.

Trial Locations (1)

Stanley Ho Centre for Emerging Infectious Diseases, Shatin

All Listed Sponsors

lead

Chinese University of Hong Kong

OTHER